C Russell Middaugh

Title: C Russell Middaugh: Innovator in Pharmaceutical Formulations

Introduction

C Russell Middaugh is a notable inventor based in Quakertown, PA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of cancer treatment. With a total of 2 patents, his work focuses on enhancing the efficacy and stability of medicinal compositions.

Latest Patents

Middaugh's latest patents include a controlled-pH formulation for intravesicular instillation. This innovative buffered intravesicular pharmaceutical dosage system is designed for the delivery of TGF.alpha.PE.sub.40 ab to the human bladder for bladder cancer chemotherapy. The formulation maintains a pH range of 6.5 to 7.8, which maximizes the interaction of TGF.alpha.PE.sub.40 ab with the EGF receptor on bladder cancer cells while preventing aggregation in the bladder. Another significant patent involves stabilizers for fibroblast growth factors. This patent describes medicinal compositions that include various stabilizing agents to maintain biological activity, ensuring effective treatment options.

Career Highlights

C Russell Middaugh is currently associated with Merck & Co., Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing formulations that improve patient outcomes in cancer therapies.

Collaborations

Middaugh has collaborated with esteemed colleagues such as Gautam Sanyal and David B Volkin. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

C Russell Middaugh's contributions to pharmaceutical formulations demonstrate his commitment to improving cancer treatment options. His innovative patents and collaborations highlight his role as a key figure in the field of medicinal chemistry.